Liu X, Chen R, Li B, Zhang J, Liu P, Li B
Int J Med Sci. 2024; 21(15):3034-3045.
PMID: 39628680
PMC: 11610340.
DOI: 10.7150/ijms.102879.
Bohra H, Suthar O, Rehana V, Baskaran P, Nivedita A, Lakra P
J Family Med Prim Care. 2024; 13(5):1856-1862.
PMID: 38948551
PMC: 11213453.
DOI: 10.4103/jfmpc.jfmpc_1304_23.
Pottecher J, Raffi F, Jandrot-Perrus M, Binay S, Comenducci A, Desort-Henin V
PLoS One. 2024; 19(6):e0302897.
PMID: 38885234
PMC: 11182546.
DOI: 10.1371/journal.pone.0302897.
Radtke T, Kunzi L, Kopp J, Rasi M, Braun J, Zens K
Trials. 2024; 25(1):385.
PMID: 38879571
PMC: 11179231.
DOI: 10.1186/s13063-024-08187-6.
Paul O, Akolia I, Qin Tao J, Jain N, Louneva N, Montone K
PLoS One. 2024; 19(5):e0289854.
PMID: 38771750
PMC: 11108150.
DOI: 10.1371/journal.pone.0289854.
Does SARS-CoV-2 infect platelets?.
Subramaniam S, Mohiuddin N, Jose A
Front Immunol. 2024; 15:1392000.
PMID: 38715614
PMC: 11074452.
DOI: 10.3389/fimmu.2024.1392000.
Signaling network analysis reveals fostamatinib as a potential drug to control platelet hyperactivation during SARS-CoV-2 infection.
Osmanoglu O, Gupta S, Almasi A, Yagci S, Srivastava M, Araujo G
Front Immunol. 2024; 14:1285345.
PMID: 38187394
PMC: 10768010.
DOI: 10.3389/fimmu.2023.1285345.
FcRIIa - dependent platelet activation identified in COVID-19 vaccine-induced immune thrombotic thrombocytopenia-, heparin-induced thrombocytopenia, streptokinase- and anisoylated plasminogen-streptokinase activator complex-induced platelet....
Abdelouahed M, Yateem D, Fredericks S
Front Cardiovasc Med. 2023; 10:1282637.
PMID: 38034388
PMC: 10684751.
DOI: 10.3389/fcvm.2023.1282637.
SARS-CoV-2 Omicron variant infection affects blood platelets, a comparative analysis with Delta variant.
Garcia C, Compagnon B, Ribes A, Voisin S, Vardon-Bounes F, Payrastre B
Front Immunol. 2023; 14:1231576.
PMID: 37828997
PMC: 10565689.
DOI: 10.3389/fimmu.2023.1231576.
Correlation between Hepatocyte Growth Factor (HGF) with D-Dimer and Interleukin-6 as Prognostic Markers of Coagulation and Inflammation in Long COVID-19 Survivors.
Zaira B, Yulianti T, Levita J
Curr Issues Mol Biol. 2023; 45(7):5725-5740.
PMID: 37504277
PMC: 10377933.
DOI: 10.3390/cimb45070361.
A Contemporary Review of Antiplatelet Therapies in Current Clinical Practice.
Arockiam S, Staniforth B, Kepreotis S, Maznyczka A, Bulluck H
Int J Mol Sci. 2023; 24(13).
PMID: 37446310
PMC: 10342577.
DOI: 10.3390/ijms241311132.
Editorial: COVID-19 and thrombo-inflammatory responses.
Subramaniam S, Reinhardt C, Kulkarni P, Spiezia L
Front Cardiovasc Med. 2023; 10:1231909.
PMID: 37396577
PMC: 10311441.
DOI: 10.3389/fcvm.2023.1231909.
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial.
Solomon S, Lowenstein C, Bhatt A, Peikert A, Vardeny O, Kosiborod M
Circulation. 2023; 148(5):381-390.
PMID: 37356038
PMC: 10373640.
DOI: 10.1161/CIRCULATIONAHA.123.065190.
Endotheliopathy in Acute COVID-19 and Long COVID.
Vassiliou A, Vrettou C, Keskinidou C, Dimopoulou I, Kotanidou A, Orfanos S
Int J Mol Sci. 2023; 24(9).
PMID: 37175942
PMC: 10179170.
DOI: 10.3390/ijms24098237.
Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond.
Sciaudone A, Corkrey H, Humphries F, Koupenova M
Circ Res. 2023; 132(10):1272-1289.
PMID: 37167360
PMC: 10171305.
DOI: 10.1161/CIRCRESAHA.122.321930.
The Long Term Residual Effects of COVID-Associated Coagulopathy.
Ranucci M, Baryshnikova E, Anguissola M, Pugliese S, Falco M, Menicanti L
Int J Mol Sci. 2023; 24(6).
PMID: 36982589
PMC: 10049638.
DOI: 10.3390/ijms24065514.
Associations Between Mean Platelet Volume and Risk of Deep Vein Thrombosis: A Mendelian Randomization Study and a Retrospective Study.
Li J, Liang Y
Int J Gen Med. 2023; 16:515-524.
PMID: 36789132
PMC: 9922513.
DOI: 10.2147/IJGM.S401059.
Redox stress in COVID-19: Implications for hematologic disorders.
Yang M
Best Pract Res Clin Haematol. 2022; 35(3):101373.
PMID: 36494143
PMC: 9374492.
DOI: 10.1016/j.beha.2022.101373.
Pathophysiological mechanisms of thrombosis in acute and long COVID-19.
Jing H, Wu X, Xiang M, Liu L, Novakovic V, Shi J
Front Immunol. 2022; 13:992384.
PMID: 36466841
PMC: 9709252.
DOI: 10.3389/fimmu.2022.992384.
Are platelet volume indices of clinical use in COVID-19? A systematic review.
Daniels S, Wei H, Van Tongeren M, Denning D
Front Cardiovasc Med. 2022; 9:1031092.
PMID: 36329999
PMC: 9623063.
DOI: 10.3389/fcvm.2022.1031092.
